Biofrontera Inc (BFRI)

Currency in USD
0.7699
-0.0101(-1.29%)
Closed·
0.7700+0.0001(+0.01%)
·

BFRI Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
-0.62 / -0.57
Revenue / Forecast
6.99M / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2025-0.62/-0.576.99M/---8.77%--Free Sign Up
06/2025-0.57/-0.579.03M/--0%--Free Sign Up
03/2025-0.47/-0.198.59M/---147.37%--Free Sign Up
12/2024-0.18/-0.212.56M/14.33M+10%-12.35%Free Sign Up
06/2023--/-0.22--/6.78M----Free Sign Up
03/2023-0.28/-0.088.7M/11.1M-250%-21.62%Free Sign Up
12/2022-0.11/-0.0710.14M/11.65M-57.14%-12.96%Free Sign Up
09/2022-0.11/-0.294.3M/4.31M+62.07%-0.23%Free Sign Up
06/2022-0.05/-0.344.46M/4.55M+85.29%-1.98%Free Sign Up
03/20220.32/-0.159.75M/9.83M+313.33%-0.81%Free Sign Up

All numbers in

Biofrontera Inc Earnings Call Summary for Q3/2025

  • Biofrontera reported Q3 2025 revenue of $7.0 million, down 22% YoY, with widened net loss of $6.6 million compared to $5.7 million in Q3 2024.
  • The company acquired full U.S. rights for key products and plans a price increase before year-end to strengthen financial position.
  • Management expects strong revenue growth in Q4 2025 and aims to reach cash flow breakeven by fiscal year 2026.
  • An FDA application for new treatment indications is scheduled for Q2 2026, with commercialization of basal cell carcinoma treatment expected by end of 2026.
  • Cost of revenues decreased by 58% due to a new pricing agreement, partially offsetting revenue decline challenges.
Last Updated: 2025-11-13, 11:10 a/m
Read Full Transcript

FAQ

What Is Biofrontera's Earnings Per Share (TTM)?

The Biofrontera EPS (TTM) is -1.92.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.